SCOPUS 정보 검색 플랫폼

Volumn 79, Issue 8, 2005, Pages 5185-5202

A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients

(17) Monie, Daphne a Simmons, Rachel P a,f Nettles, Richard E a Kieffer, Tara L a Zhou, Yan a Zhang, Haili a Karmon, Sharon a Ingersoll, Roxann a Chadwick, Karen b Zhang, Hao b Margolick, Joseph B b Quinn, Thomas C a,d Ray, Stuart C a Wind Rotolo, Megan a Miller, Michael e Persaud, Deborah a Siliciano, Robert F a,c

a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (United States)

b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH (United States)

c HOWARD HUGHES MEDICAL INSTITUTE (United States)

d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (United States)

e MERCK RESEARCH LABORATORIES (United States)

f MASSACHUSETTS GENERAL HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [1 (4 FLUOROBENZYL) 2 PYRROLYL] 2,4 DIOXOBUTYRIC ACID; ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INTEGRASE INHIBITOR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TENOFOVIR; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; STIMULATION; T LYMPHOCYTE; TREATMENT FAILURE; VIREMIA; VIRUS ACTIVATION; VIRUS CULTURE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE; WILD TYPE;

ANTI-HIV AGENTS; ANTIGENS, CD; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; DISEASE RESERVOIRS; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; VIREMIA; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 20144386688 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.79.8.5185-5202.2005 Document Type: Article

Times cited : (31)

References (79)

1
- 0029757751
- Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme
- Back, N. K. T., M. Nijhuis, W. Keulen, C. A. B. Boucher, B. B. O. Essink, A. B. P. vanKuilenburg, A. H. vanGennip, and B. Berkhout. 1996. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:4040-4049.
- (1996) EMBO J. , vol.15 , pp. 4040-4049
- Back, N.K.T.¹ Nijhuis, M.² Keulen, W.³ Boucher, C.A.B.⁴ Essink, B.B.O.⁵ VanKuilenburg, A.B.P.⁶ VanGennip, A.H.⁷ Berkhout, B.⁸

2
- 2442689168
- Paradoxes of adherence and drug resistance to HIV antretroviral therapy
- Bangsberg, D. R., A. R. Moss, and S. G. Deeks. 2004. Paradoxes of adherence and drug resistance to HIV antretroviral therapy. J. Antimicrob. Chemother. 53:696-699.
- (2004) J. Antimicrob. Chemother. , vol.53 , pp. 696-699
- Bangsberg, D.R.¹ Moss, A.R.² Deeks, S.G.³

3
- 0034303872
- Proviral HIV-1 dynamics and evolution in patients receiving efficient long-term antiretroviral combination therapy
- Birk, M., S. Aleman, U. Visco-Comandini, and A. Sonnerborg. 2000. Proviral HIV-1 dynamics and evolution in patients receiving efficient long-term antiretroviral combination therapy. HIV Med. 1:205-211.
- (2000) HIV Med. , vol.1 , pp. 205-211
- Birk, M.¹ Aleman, S.² Visco-Comandini, U.³ Sonnerborg, A.⁴

4
- 0033681160
- + T cells in acute human immunodeficiency virus type 1 infection
- + T cells in acute human immunodeficiency virus type 1 infection. J. Infect. Dis. 182:1636-1642.
- (2000) J. Infect. Dis. , vol.182 , pp. 1636-1642
- Blankson, J.N.¹ Finzi, D.² Pierson, T.C.³ Sabundayo, B.P.⁴ Chadwick, K.⁵ Margolick, J.B.⁶ Quinn, T.C.⁷ Siliciano, R.F.⁸

5
- 0036176509
- The challenge of viral reservoirs in HIV-1 infection
- Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
- (2002) Annu. Rev. Med. , vol.53 , pp. 557-593
- Blankson, J.N.¹ Persaud, D.² Siliciano, R.F.³

6
- 0026054892
- Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
- Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
- (1991) Science , vol.254 , pp. 423-427
- Bukrinsky, M.I.¹ Stanwick, T.L.² Dempsey, M.P.³ Stevenson, M.⁴

7
- 0030913366
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
- Chun, T. W., L. Carruth, D. Finzi, X. F. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, Y. H. Kuo, R. Brookmeyer, M. A. Zeiger, P. BarditchCrovo, and R. F. Siliciano. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
- (1997) Nature , vol.387 , pp. 183-188
- Chun, T.W.¹ Carruth, L.² Finzi, D.³ Shen, X.F.⁴ Digiuseppe, J.A.⁵ Taylor, H.⁶ Hermankova, M.⁷ Chadwick, K.⁸ Margolick, J.⁹ Quinn, T.C.¹⁰ Kuo, Y.H.¹¹ Brookmeyer, R.¹² Zeiger, M.A.¹³ Barditchcrovo, P.¹⁴ Siliciano, R.F.¹⁵

8
- 0033914367
- Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
- Chun, T. W., R. T. Davey, M. Ostrowski, J. S. Justement, D. Engel, J. I. Mullins, and A. S. Fauci. 2000. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med. 6:757-761.
- (2000) Nat. Med. , vol.6 , pp. 757-761
- Chun, T.W.¹ Davey, R.T.² Ostrowski, M.³ Justement, J.S.⁴ Engel, D.⁵ Mullins, J.I.⁶ Fauci, A.S.⁷

9
- 0032555117
- + T cells during primary HIV-1 infection
- + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869-8873.
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 8869-8873
- Chun, T.W.¹ Engel, D.² Berrey, M.M.³ Shea, T.⁴ Corey, L.⁵ Fauci, A.S.⁶

10
- 0028792184
- In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
- Chun, T. W., D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284-1290.
- (1995) Nat. Med. , vol.1 , pp. 1284-1290
- Chun, T.W.¹ Finzi, D.² Margolick, J.³ Chadwick, K.⁴ Schwartz, D.⁵ Siliciano, R.F.⁶

11
- 0037452711
- + T cells in viremic versus aviremic HIV-infected individuals
- + T cells in viremic versus aviremic HIV-infected individuals. Proc. Natl. Acad. Sci. USA 100:1908-1913.
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 1908-1913
- Chun, T.W.¹ Justement, J.S.² Lempicki, R.A.³ Yang, J.⁴ Dennis, G.⁵ Hallahan, C.W.⁶ Sanford, C.⁷ Pandya, P.⁸ Liu, S.Y.⁹ McLaughlin, M.¹⁰ Ehler, L.A.¹¹ Moir, S.¹² Fauci, A.S.¹³

12
- 0030659177
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
- Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
- (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 13193-13197
- Chun, T.W.¹ Stuyver, L.² Mizell, S.B.³ Ehler, L.A.⁴ Mican, J.A.M.⁵ Baseler, M.⁶ Lloyd, A.L.⁷ Nowak, M.A.⁸ Fauci, A.S.⁹

13
- 1442355578
- Medical progress: HIV drug resistance
- Clavel, F., and A. J. Hance. 2004. Medical progress: HIV drug resistance. N. Engl. J. Med. 350:1023-1035.
- (2004) N. Engl. J. Med. , vol.350 , pp. 1023-1035
- Clavel, F.¹ Hance, A.J.²

14
- 0028952146
- HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
- Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
- (1995) Science , vol.267 , pp. 483-489
- Coffin, J.M.¹

15
- 0031015475
- Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors
- Croteau, G., L. Doyon, D. Thibeault, G. McKercher, L. Pilote, and D. Lamarre. 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J. Virol. 71:1089-1096.
- (1997) J. Virol. , vol.71 , pp. 1089-1096
- Croteau, G.¹ Doyon, L.² Thibeault, D.³ McKercher, G.⁴ Pilote, L.⁵ Lamarre, D.⁶

16
- 0035864943
- Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
- Decks, S. G., T. Wrin, T. Liegler, R. Hoh, M. Hayden, J. D. Barbour, N. S. Hellmann, C. J. Petropoulos, J. M. Mccune, M. K. Hellerstein, and R. M. Grant. 2001. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N. Engl. J. Med. 344:472-480.
- (2001) N. Engl. J. Med. , vol.344 , pp. 472-480
- Decks, S.G.¹ Wrin, T.² Liegler, T.³ Hoh, R.⁴ Hayden, M.⁵ Barbour, J.D.⁶ Hellmann, N.S.⁷ Petropoulos, C.J.⁸ Mccune, J.M.⁹ Hellerstein, M.K.¹⁰ Grant, R.M.¹¹

17
- 0034639473
- Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
- Descamps, D., P. Flandre, V. Calvez, G. Peytavin, V. Meiffredy, G. Collin, C. Delaugerre, S. Robert-Delmas, B. Bazin, J. P. Aboulker, G. Pialoux, F. Raffi, and F. Brun-Vezinet. 2000. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA 283:205-211.
- (2000) JAMA , vol.283 , pp. 205-211
- Descamps, D.¹ Flandre, P.² Calvez, V.³ Peytavin, G.⁴ Meiffredy, V.⁵ Collin, G.⁶ Delaugerre, C.⁷ Robert-Delmas, S.⁸ Bazin, B.⁹ Aboulker, J.P.¹⁰ Pialoux, G.¹¹ Raffi, F.¹² Brun-Vezinet, F.¹³

18
- 0034691650
- Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients
- Devereux, H. L., C. Loveday, M. Youle, C. A. Sabin, A. Burke, and M. Johnson. 2000. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res. Hum. Retrovir. 16:1025-1030.
- (2000) AIDS Res. Hum. Retrovir. , vol.16 , pp. 1025-1030
- Devereux, H.L.¹ Loveday, C.² Youle, M.³ Sabin, C.A.⁴ Burke, A.⁵ Johnson, M.⁶

19
- 0033520673
- Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
- Dornadula, G., H. Zhang, B. VanUitert, J. Stern, L Livornese, M. J. Ingerman, J. Witek, R. J. Kedanis, J. Natkin, J. DeSimone, and R. J. Pomerantz. 1999. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 282:1627-1632.
- (1999) JAMA , vol.282 , pp. 1627-1632
- Dornadula, G.¹ Zhang, H.² VanUitert, B.³ Stern, J.⁴ Livornese, L.⁵ Ingerman, M.J.⁶ Witek, J.⁷ Kedanis, R.J.⁸ Natkin, J.⁹ DeSimone, J.¹⁰ Pomerantz, R.J.¹¹

20
- 0037369101
- Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy
- Dybul, M., M. Daucher, M. A. Jensen, C. W. Hallahan, T. W. Chun, M. Belson, B. Hidalgo, D. C. Nickle, C. Yoder, J. A. Metcalf, R. T. Davey, L. Ehler, D. Kress-Rock, E. Nies-Kraske, S. Y. Liu, J. I. Mullins, and A. S. Fauci. 2003. Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J. Virol. 77:3229-3237.
- (2003) J. Virol. , vol.77 , pp. 3229-3237
- Dybul, M.¹ Daucher, M.² Jensen, M.A.³ Hallahan, C.W.⁴ Chun, T.W.⁵ Belson, M.⁶ Hidalgo, B.⁷ Nickle, D.C.⁸ Yoder, C.⁹ Metcalf, J.A.¹⁰ Davey, R.T.¹¹ Ehler, L.¹² Kress-Rock, D.¹³ Nies-Kraske, E.¹⁴ Liu, S.Y.¹⁵ Mullins, J.I.¹⁶ Fauci, A.S.¹⁷

21
- 0029563673
- + cells per cubic millimeter
- + cells per cubic millimeter. N. Engl. J. Med. 333:1662-1669.
- (1995) N. Engl. J. Med. , vol.333 , pp. 1662-1669
- Eron, J.J.¹ Benoit, S.L.² Jemsek, J.³ Macarthur, R.D.⁴ Santana, J.⁵ Quinn, J.B.⁶ Kuritzkes, D.R.⁷ Fallon, M.A.⁸ Rubin, M.⁹

22
- 0032953920
- + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
- + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
- (1999) Nat. Med. , vol.5 , pp. 512-517
- Finzi, D.¹ Blankson, J.² Siliciano, J.D.³ Margolick, J.B.⁴ Chadwick, K.⁵ Pierson, T.⁶ Smith, K.⁷ Lisziewicz, J.⁸ Lori, F.⁹ Flexner, C.¹⁰ Quinn, T.C.¹¹ Chaisson, R.E.¹² Rosenberg, E.¹³ Walker, B.¹⁴ Gange, S.¹⁵ Gallant, J.¹⁶ Siliciano, R.F.¹⁷

23
- 14444273439
- Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
- Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
- (1997) Science , vol.278 , pp. 1295-1300
- Finzi, D.¹ Hermankova, M.² Pierson, T.³ Carruth, L.M.⁴ Buck, C.⁵ Chaisson, R.E.⁶ Quinn, T.C.⁷ Chadwick, K.⁸ Margolick, J.⁹ Brookmeyer, R.¹⁰ Gallant, J.¹¹ Markowitz, M.¹² Ho, D.D.¹³ Richman, D.D.¹⁴ Siliciano, R.F.¹⁵

24
- 0030926277
- Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215
- Goudsmit, J., A. DeRonde, E. DeRooij, and R. DeBoer. 1997. Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J. Virol. 71:4479-4484.
- (1997) J. Virol. , vol.71 , pp. 4479-4484
- Goudsmit, J.¹ DeRonde, A.² DeRooij, E.³ DeBoer, R.⁴

25
- 0030869269
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
- Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734-739.
- (1997) N. Engl. J. Med. , vol.337 , pp. 734-739
- Gulick, R.M.¹ Mellors, J.W.² Havlir, D.³ Eron, J.J.⁴ Gonzalez, C.⁵ McMahon, D.⁶ Richman, D.D.⁷ Valentine, F.T.⁸ Jonas, L.⁹ Meibohm, A.¹⁰ Emini, E.A.¹¹ Chodakewitz, J.A.¹²

26
- 0242629783
- Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
- Gunthard, H. F., S. D. W. Frost, A. J. Leigh-Brown, C. C. Ignacio, K. Kee, A. S. Perelson, C. A. Spina, D. V. Havlir, M. Hezareh, D. J. Looney, D. D. Richman, and J. K. Wong. 1999. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J. Virol. 73:9404-9412.
- (1999) J. Virol. , vol.73 , pp. 9404-9412
- Gunthard, H.F.¹ Frost, S.D.W.² Leigh-Brown, A.J.³ Ignacio, C.C.⁴ Kee, K.⁵ Perelson, A.S.⁶ Spina, C.A.⁷ Havlir, D.V.⁸ Hezareh, M.⁹ Looney, D.J.¹⁰ Richman, D.D.¹¹ Wong, J.K.¹²

27
- 0442268112
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
- Hammer, S. M., K. E. Squires, M. D. Hughes, J. M. Grimes, L. M. Demeter, J. S. Currier, J. J. Eron, J. E. Feinberg, H. H. Balfour, L. R. Dayton, J. A. Chodakewitz, and M. A. Fischl. 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:725-733.
- (1997) N. Engl. J. Med. , vol.337 , pp. 725-733
- Hammer, S.M.¹ Squires, K.E.² Hughes, M.D.³ Grimes, J.M.⁴ Demeter, L.M.⁵ Currier, J.S.⁶ Eron, J.J.⁷ Feinberg, J.E.⁸ Balfour, H.H.⁹ Dayton, L.R.¹⁰ Chodakewitz, J.A.¹¹ Fischl, M.A.¹²

28
- 0034639490
- Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
- Havlir, D. V., N. S. Hellmann, C. J. Petropoulos, J. M. Whitcomb, A. C. Collier, M. S. Hirsch, P. Tebas, J. P. Sommadossi, and D. D. Richman. 2000. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA 283:229-234.
- (2000) JAMA , vol.283 , pp. 229-234
- Havlir, D.V.¹ Hellmann, N.S.² Petropoulos, C.J.³ Whitcomb, J.M.⁴ Collier, A.C.⁵ Hirsch, M.S.⁶ Tebas, P.⁷ Sommadossi, J.P.⁸ Richman, D.D.⁹

29
- 0037241329
- Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection
- Heath, K. V., J. S. G. Montaner, G. Bondy, J. Singer, M. V. O'Shaughnessy, and R. S. Hogg. 2003. Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. Curr. Drug Targets 4:13-22.
- (2003) Curr. Drug Targets , vol.4 , pp. 13-22
- Heath, K.V.¹ Montaner, J.S.G.² Bondy, G.³ Singer, J.⁴ O'Shaughnessy, M.V.⁵ Hogg, R.S.⁶

30
- 0034946886
- HIV-1 drug resistance profiles in children and adults with viral load of < 50 copies/mL receiving combination therapy
- Hermankova, M., S. C. Ray, C. Ruff, M. Powell-Davis, R. Ingersoll, R. T. D'Aquila, T. C. Quinn, R. F. Siliciano, and D. Persaud. 2001. HIV-1 drug resistance profiles in children and adults with viral load of < 50 copies/mL receiving combination therapy. JAMA 286:196-207.
- (2001) JAMA , vol.286 , pp. 196-207
- Hermankova, M.¹ Ray, S.C.² Ruff, C.³ Powell-Davis, M.⁴ Ingersoll, R.⁵ D'Aquila, R.T.⁶ Quinn, T.C.⁷ Siliciano, R.F.⁸ Persaud, D.⁹

31
- 0038468339
- + T lymphocytes in vivo
- + T lymphocytes in vivo. J. Virol. 77:7383-7392.
- (2003) J. Virol. , vol.77 , pp. 7383-7392
- Hermankova, M.¹ Siliciano, J.D.² Zhou, Y.³ Monie, D.⁴ Chadwick, K.⁵ Margolick, J.B.⁶ Quinn, T.C.⁷ Siliciano, R.F.⁸

32
- 0028874048
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
- Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
- (1995) Nature , vol.373 , pp. 123-126
- Ho, D.D.¹ Neumann, A.U.² Perelson, A.S.³ Chen, W.⁴ Leonard, J.M.⁵ Markowitz, M.⁶

33
- 0035173896
- Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy
- Imamichi, H., K. A. Crandall, V. Natarajan, M. K. Jiang, R. L. Dewar, S. Berg, A. Gaddam, M. Bosche, J. A. Metcalf, R. T. Davey, and H. C. Lane. 2001. Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J. Infect. Dis. 183:36-50.
- (2001) J. Infect. Dis. , vol.183 , pp. 36-50
- Imamichi, H.¹ Crandall, K.A.² Natarajan, V.³ Jiang, M.K.⁴ Dewar, R.L.⁵ Berg, S.⁶ Gaddam, A.⁷ Bosche, M.⁸ Metcalf, J.A.⁹ Davey, R.T.¹⁰ Lane, H.C.¹¹

34
- 0035577434
- + T lymphocytes in untreated and suboptimally treated subjects
- + T lymphocytes in untreated and suboptimally treated subjects. J. Infect. Dis. 184:1392-1401.
- (2001) J. Infect. Dis. , vol.184 , pp. 1392-1401
- Karlsson, A.C.¹ Lindkvist, A.² Lindback, S.³ Gaines, H.⁴ Sonnerborg, A.⁵

35
- 2142829435
- Genotypic analysis of HIV-1 drug resistance at the limit of detection: Virus production without evolution in treated adults with undetectable HIV loads
- Kieffer, T. L., M. M. Finucane, R. E. Nettles, T. C. Quinn, K. W. Broman, S. C. Ray, D. Persaud, and R. F. Siliciano. 2004. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J. Infect. Dis. 189:1452-1465.
- (2004) J. Infect. Dis. , vol.189 , pp. 1452-1465
- Kieffer, T.L.¹ Finucane, M.M.² Nettles, R.E.³ Quinn, T.C.⁴ Broman, K.W.⁵ Ray, S.C.⁶ Persaud, D.⁷ Siliciano, R.F.⁸

36
- 0032795284
- 0 lymphocytes
- 0 lymphocytes. J. Virol. 73:6526-6532.
- (1999) J. Virol. , vol.73 , pp. 6526-6532
- Korin, Y.D.¹ Zack, J.A.²

37
- 0036139211
- MEGA2: Molecular evolutionary genetics software
- 36a. Kumar, S., K. Tamura, I. B. Jacobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics software. Bioinformatics 17:1244-1245.
- (2001) Bioinformatics , vol.17 , pp. 1244-1245
- Kumar, S.¹ Tamura, K.² Jacobsen, I.B.³ Nei, M.⁴

38
- 2942618578
- The lymphocyte HIV réservoir in patients on long-term HAART is a memory of virus evolution
- Lambotte, O., M. L. Chaix, B. Gubler, N. Nasreddine, C. Wallon, C. Goujard, C. Rouzioux, Y. Taoufik, and J. F. Delfraissy. 2004. The lymphocyte HIV réservoir in patients on long-term HAART is a memory of virus evolution. AIDS 18:1147-1158.
- (2004) AIDS , vol.18 , pp. 1147-1158
- Lambotte, O.¹ Chaix, M.L.² Gubler, B.³ Nasreddine, N.⁴ Wallon, C.⁵ Goujard, C.⁶ Rouzioux, C.⁷ Taoufik, Y.⁸ Delfraissy, J.F.⁹

39
- 0024508058
- HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
- Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
- (1989) Science , vol.243 , pp. 1731-1734
- Larder, B.A.¹ Darby, G.² Richman, D.D.³

40
- 0027486945
- Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro
- Larder, B. A., P. Kellam, and S. D. Kemp. 1993. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 365:451-453.
- (1993) Nature , vol.365 , pp. 451-453
- Larder, B.A.¹ Kellam, P.² Kemp, S.D.³

41
- 4143061435
- + T cells in vivo
- + T cells in vivo. J. Virol. 78:9105-9114.
- (2004) J. Virol. , vol.78 , pp. 9105-9114
- Lassen, K.G.¹ Bailey, J.R.² Siliciano, R.F.³

42
- 12944335238
- Antiretroviral resistance during successful therapy of HIV type 1 infection
- Martinez-Picado, J., M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E, Rosenberg, H. F. Gunthard, L. Sutton, A. Savara, C. J. Petropoulos, N. Hellmann, B. D. Walker, D. D. Richman, R. Siliciano, and R. T. D'Aquila. 2000. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc. Natl. Acad. Sci. USA 97:10948-10953.
- (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 10948-10953
- Martinez-Picado, J.¹ DePasquale, M.P.² Kartsonis, N.³ Hanna, G.J.⁴ Wong, J.⁵ Finzi, D.⁶ Rosenberg, E.⁷ Gunthard, H.F.⁸ Sutton, L.⁹ Savara, A.¹⁰ Petropoulos, C.J.¹¹ Hellmann, N.¹² Walker, B.D.¹³ Richman, D.D.¹⁴ Siliciano, R.¹⁵ D'Aquila, R.T.¹⁶

43
- 0032937011
- Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro
- Miller, M. D., K. E. Anton, A. S. Mulato, P. D. Lamy, and J. M. Cherrington. 1999. Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro. J. Infect. Dis. 179:92-100.
- (1999) J. Infect. Dis. , vol.179 , pp. 92-100
- Miller, M.D.¹ Anton, K.E.² Mulato, A.S.³ Lamy, P.D.⁴ Cherrington, J.M.⁵

44
- 0032565098
- A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial
- Montaner, J. S. G., P. Reiss, D. Cooper, S. Vella, M. Harris, B. Conway, M. A. Wainberg, D. Smith, P. Robinson, D. Hall, M. Myers, and J. M. A. Lange. 1998. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial. JAMA 279:930-937.
- (1998) JAMA , vol.279 , pp. 930-937
- Montaner, J.S.G.¹ Reiss, P.² Cooper, D.³ Vella, S.⁴ Harris, M.⁵ Conway, B.⁶ Wainberg, M.A.⁷ Smith, D.⁸ Robinson, P.⁹ Hall, D.¹⁰ Myers, M.¹¹ Lange, J.M.A.¹²

45
- 0037405163
- Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments
- Nickle, D. C., M. A. Jensen, D. Shriner, S. J. Brodie, L. M. Frenkel, J. E. Mittler, and J. I. Mullins. 2003. Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J. Virol. 77:5540-5546.
- (2003) J. Virol. , vol.77 , pp. 5540-5546
- Nickle, D.C.¹ Jensen, M.A.² Shriner, D.³ Brodie, S.J.⁴ Frenkel, L.M.⁵ Mittler, J.E.⁶ Mullins, J.I.⁷

46
- 0033780046
- Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
- O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
- (2000) J. Virol. , vol.74 , pp. 10074-10080
- O'Doherty, U.¹ Swiggard, W.J.² Malim, M.H.³

47
- 0033022106
- Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development
- Palmer, S., R. W. Shafer, and T. C. Merigan. 1999. Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. AIDS 13:661-667.
- (1999) AIDS , vol.13 , pp. 661-667
- Palmer, S.¹ Shafer, R.W.² Merigan, T.C.³

48
- 0024161111
- Phenotypic and functional characterization of human T-cell clones
- Patel, S. S., A. D. Duby, D. L. Thiele, and P. E. Lipsky. 1988. Phenotypic and functional characterization of human T-cell clones. J. Immunol. 141:3726-3736.
- (1988) J. Immunol. , vol.141 , pp. 3726-3736
- Patel, S.S.¹ Duby, A.D.² Thiele, D.L.³ Lipsky, P.E.⁴

49
- 0034604276
- Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
- Paterson, D. L., S. Swindells, J. Mohr, M. Brester, E. N. Vergis, C. Squier, M. M. Wagener, and N. Singh. 2000. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Int. Med. 133:21-30.
- (2000) Ann. Int. Med. , vol.133 , pp. 21-30
- Paterson, D.L.¹ Swindells, S.² Mohr, J.³ Brester, M.⁴ Vergis, E.N.⁵ Squier, C.⁶ Wagener, M.M.⁷ Singh, N.⁸

50
- 0030952479
- Decay characteristics of HIV-1-infected compartments during combination therapy
- Perelson, A. S., P. Essunger, Y. Z. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191.
- (1997) Nature , vol.387 , pp. 188-191
- Perelson, A.S.¹ Essunger, P.² Cao, Y.Z.³ Vesanen, M.⁴ Hurley, A.⁵ Saksela, K.⁶ Markowitz, M.⁷ Ho, D.D.⁸

51
- 0029967721
- HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
- Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
- (1996) Science , vol.271 , pp. 1582-1586
- Perelson, A.S.¹ Neumann, A.U.² Markowitz, M.³ Leonard, J.M.⁴ Ho, D.D.⁵

52
- 0034076571
- + T lymphocytes in infected children
- + T lymphocytes in infected children. J. Clin. Investig. 105:995-1003.
- (2000) J. Clin. Investig. , vol.105 , pp. 995-1003
- Persaud, D.¹ Pierson, T.² Ruff, C.³ Finzi, D.⁴ Chadwick, K.R.⁵ Margolick, J.B.⁶ Ruff, A.⁷ Hutton, N.⁸ Ray, S.⁹ Siliciano, R.F.¹⁰

53
- 9144270766
- Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads
- Persaud, D., G. K. Siberry, A. Ahonkhai, J. Kajdas, D. Monie, N. Hutton, D. C. Watson, T. C. Quinn, S. C. Ray, and R. F. Siliciano. 2004. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J. Virol. 78:968-979.
- (2004) J. Virol. , vol.78 , pp. 968-979
- Persaud, D.¹ Siberry, G.K.² Ahonkhai, A.³ Kajdas, J.⁴ Monie, D.⁵ Hutton, N.⁶ Watson, D.C.⁷ Quinn, T.C.⁸ Ray, S.C.⁹ Siliciano, R.F.¹⁰

54
- 0036340605
- Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
- Pierson, T. C., Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76:8518-8531.
- (2002) J. Virol. , vol.76 , pp. 8518-8531
- Pierson, T.C.¹ Zhou, Y.² Kieffer, T.L.³ Ruff, C.T.⁴ Buck, C.⁵ Siliciano, R.F.⁶

55
- 0033984045
- The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
- Ramratnam, B., J. E. Mittler, L. Q. Zhang, D. Boden, A. Hurley, F. Fang, C. A. Macken, A. S. Perelson, M. Markowitz, and D. D. Ho. 2000. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6:82-85.
- (2000) Nat. Med. , vol.6 , pp. 82-85
- Ramratnam, B.¹ Mittler, J.E.² Zhang, L.Q.³ Boden, D.⁴ Hurley, A.⁵ Fang, F.⁶ Macken, C.A.⁷ Perelson, A.S.⁸ Markowitz, M.⁹ Ho, D.D.¹⁰

56
- 0036720438
- Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure
- Ruff, C. T., S. C. Ray, P. Kwon, R. Zinn, A. Pendleton, N. Hutton, R. Ashworth, S. Gange, T. C. Quinn, R. F. Siliciano, and D. Persaud. 2002. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 76:9481-9492.
- (2002) J. Virol. , vol.76 , pp. 9481-9492
- Ruff, C.T.¹ Ray, S.C.² Kwon, P.³ Zinn, R.⁴ Pendleton, A.⁵ Hutton, N.⁶ Ashworth, R.⁷ Gange, S.⁸ Quinn, T.C.⁹ Siliciano, R.F.¹⁰ Persaud, D.¹¹

57
- 12444317538
- Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing
- Sarmati, L., E. Nicastri, I. Uccella, G. d'Ettorre, S. G. Parisi, L. Palmisano, C. Galluzzo, E. Concia, V. Vullo, S. Vella, and M. Andreoni. 2003. Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J. Clin. Microbiol. 41:1760-1762.
- (2003) J. Clin. Microbiol. , vol.41 , pp. 1760-1762
- Sarmati, L.¹ Nicastri, E.² Uccella, I.³ D'Ettorre, G.⁴ Parisi, S.G.⁵ Palmisano, L.⁶ Galluzzo, C.⁷ Concia, E.⁸ Vullo, V.⁹ Vella, S.¹⁰ Andreoni, M.¹¹

58
- 0035873713
- + T cells lacking activation markers support HIV replication during immune activation
- + T cells lacking activation markers support HIV replication during immune activation. J. Immunol. 166:6437-6443.
- (2001) J. Immunol. , vol.166 , pp. 6437-6443
- Scales, D.¹ Ni, H.P.² Shaheen, F.³ Capodici, J.⁴ Cannon, G.⁵ Weissman, D.⁶

59
- 0033678531
- Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
- Shafer, R. W., D. R. Jung, and B. J. Betts. 2000. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries. Nat. Med. 6:1290-1292.
- (2000) Nat. Med. , vol.6 , pp. 1290-1292
- Shafer, R.W.¹ Jung, D.R.² Betts, B.J.³

60
- 0038579210
- + T cells
- + T cells. Nat. Med. 9:727-728.
- (2003) Nat. Med. , vol.9 , pp. 727-728
- Siliciano, J.D.¹ Kajdas, J.² Finzi, D.³ Quinn, T.C.⁴ Chadwick, K.⁵ Margolick, J.B.⁶ Kovacs, C.⁷ Gange, S.J.⁸ Siliciano, R.F.⁹

61
- 0030878535
- Virus "quasispecies": Making a mountain out of a molehill?
- Smith, D. B., J. McAllister, C. Casino, and P. Simmonds. 1997. Virus "quasispecies": making a mountain out of a molehill? J. Gen. Virol. 78:1511-1519.
- (1997) J. Gen. Virol. , vol.78 , pp. 1511-1519
- Smith, D.B.¹ McAllister, J.² Casino, C.³ Simmonds, P.⁴

62
- 0028958338
- Establishment of a stable, inducible form of human immunodeficiency virus type-1 DNA in quiescent CD4 lymphocytes in vitro
- Spina, C. A., J. C. Guatelli, and D. D. Richman. 1995. Establishment of A stable, inducible form of human immunodeficiency virus type-1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69:2977-2988.
- (1995) J. Virol. , vol.69 , pp. 2977-2988
- Spina, C.A.¹ Guatelli, J.C.² Richman, D.D.³

63
- 0242584383
- Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence
- Strain, M. C., H. F. Gunthard, D. V. Havlir, C. C. Igoacio, D. M. Smith, A. J. Leigh-Brown, T. R. Macaranas, R. Y. Lam, O. A. Daly, M. Fischer, M. Opravil, H. Levine, L. Bacheler, C. A. Spina, D. D. Richman, and J. K. Wong. 2003. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. USA 100:4819-4824.
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 4819-4824
- Strain, M.C.¹ Gunthard, H.F.² Havlir, D.V.³ Igoacio, C.C.⁴ Smith, D.M.⁵ Leigh-Brown, A.J.⁶ Macaranas, T.R.⁷ Lam, R.Y.⁸ Daly, O.A.⁹ Fischer, M.¹⁰ Opravil, M.¹¹ Levine, H.¹² Bacheler, L.¹³ Spina, C.A.¹⁴ Richman, D.D.¹⁵ Wong, J.K.¹⁶

64
- 1842554843
- + T cells while short ones are degraded
- + T cells while short ones are degraded. AIDS Res. Hum. Retrovir. 20:285-295.
- (2004) AIDS Res. Hum. Retrovir. , vol.20 , pp. 285-295
- Swiggard, W.J.¹ O'Doherty, U.² McGain, D.³ Jeyakumar, D.⁴ Malim, M.H.⁵

65
- 0027285372
- Rapid in vitro selection of human immunodeficiency virus type-1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
- Tisdale, M., S. D. Kemp, N. R. Parry, and B. A. Larder. 1993. Rapid in vitro selection of human immunodeficiency virus type-1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. USA 90:5653-5656.
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 5653-5656
- Tisdale, M.¹ Kemp, S.D.² Parry, N.R.³ Larder, B.A.⁴

66
- 0033532628
- Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
- Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189:1735-1746.
- (1999) J. Exp. Med. , vol.189 , pp. 1735-1746
- Unutmaz, D.¹ KewalRamani, V.N.² Marmon, S.³ Littman, D.R.⁴

67
- 0030469959
- Patient compliance and drug failure in protease inhibitor monotherapy
- Vanhove, G. F., J. M. Schapiro, M. A. Winters, T. C. Merigan, and T. F. Blaschke. 1996. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 276:1955-1956.
- (1996) JAMA , vol.276 , pp. 1955-1956
- Vanhove, G.F.¹ Schapiro, J.M.² Winters, M.A.³ Merigan, T.C.⁴ Blaschke, T.F.⁵

68
- 1842458366
- Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy
- Verhofstede, C., A. Noe, E. Demecheleer, N. De Cabooter, F. Van Wanzeele, B. Van Der Gucht, D. Vogelaers, and J. Plum. 2004. Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 35:473-483.
- (2004) J. Acquir. Immune Defic. Syndr. , vol.35 , pp. 473-483
- Verhofstede, C.¹ Noe, A.² Demecheleer, E.³ De Cabooter, N.⁴ Van Wanzeele, F.⁵ Van Der Gucht, B.⁶ Vogelaers, D.⁷ Plum, J.⁸

69
- 20644436472
- In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA
- Wainberg, M. A., M. D. Miller, Y. D. Quan, H. Salomon, A. S. Mulato, P. D. Lamy, N. A. Margot, K. E. Anton, and J. M. Cherrington. 1999. In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Antivir. Ther. 4:87-94.
- (1999) Antivir. Ther. , vol.4 , pp. 87-94
- Wainberg, M.A.¹ Miller, M.D.² Quan, Y.D.³ Salomon, H.⁴ Mulato, A.S.⁵ Lamy, P.D.⁶ Margot, N.A.⁷ Anton, K.E.⁸ Cherrington, J.M.⁹

70
- 0028811974
- Viral dynamics in human immunodeficiency virus type-1 infection
- Wei, X. P., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type-1 infection. Nature 373:117-122.
- (1995) Nature , vol.373 , pp. 117-122
- Wei, X.P.¹ Ghosh, S.K.² Taylor, M.E.³ Johnson, V.A.⁴ Emini, E.A.⁵ Deutsch, P.⁶ Lifson, J.D.⁷ Bonhoeffer, S.⁸ Nowak, M.A.⁹ Hahn, B.H.¹⁰ Saag, M.S.¹¹ Shaw, G.M.¹²

71
- 0030712305
- Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
- Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
- (1997) Science , vol.278 , pp. 1291-1295
- Wong, J.K.¹ Hezareh, M.² Gunthard, H.F.³ Havlir, D.V.⁴ Ignacio, C.C.⁵ Spina, C.A.⁶ Richman, D.D.⁷

72
- 0025342694
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
- Zack, J. A., S. J. Arrigo, S. R. Weitsman, A, S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
- (1990) Cell , vol.61 , pp. 213-222
- Zack, J.A.¹ Arrigo, S.J.² Weitsman, S.R.³ Go, S.⁴ Haislip, A.⁵ Chen, I.S.Y.⁶

73
- 0026526144
- Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
- Zacic, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.
- (1992) J. Virol. , vol.66 , pp. 1717-1725
- Zacic, J.A.¹ Haislip, A.M.² Krogstad, P.³ Chen, I.S.Y.⁴

74
- 1242307487
- Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype
- Zazzi, M., L. Romano, G. Venturi, R. W. Shafer, C. Reid, F. Dal Bello, C. Parolin, G. Palu, and P. E. Valensin. 2004. Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype. J. Antimicrob. Chemother. 53:356-360.
- (2004) J. Antimicrob. Chemother. , vol.53 , pp. 356-360
- Zazzi, M.¹ Romano, L.² Venturi, G.³ Shafer, R.W.⁴ Reid, C.⁵ Dal Bello, F.⁶ Parolin, C.⁷ Palu, G.⁸ Valensin, P.E.⁹

75
- 0031946007
- Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
- Zennou, V., F. Mammano, S. Paulous, D. Mathez, and F. Clavel. 1998. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J. Virol 72:3300-3306.
- (1998) J. Virol. , vol.72 , pp. 3300-3306
- Zennou, V.¹ Mammano, F.² Paulous, S.³ Mathez, D.⁴ Clavel, F.⁵

76
- 10744230171
- Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1
- Zhang, H. L., Y. Zhou, C. Alcock, T. Kiefer, D. Monie, J. Siliciano, Q. Li, P. Pham, J. Cofrancesco, D. Persaud, and R, F. Siliciano. 2004. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 78:1718-1729.
- (2004) J. Virol. , vol.78 , pp. 1718-1729
- Zhang, H.L.¹ Zhou, Y.² Alcock, C.³ Kiefer, T.⁴ Monie, D.⁵ Siliciano, J.⁶ Li, Q.⁷ Pham, P.⁸ Cofrancesco, J.⁹ Persaud, D.¹⁰ Siliciano, R.F.¹¹

77
- 0033797161
- Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
- Zhang, L. Q., C. Chung, B. S. Hu, T. He, Y. Guo, A. J. Kim, E. Skulsky, X. Jin, A. Hurley, B. Ramratnam, M. Markowitz, and D. D. Ho. 2000. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Investig. 106:839-845.
- (2000) J. Clin. Investig. , vol.106 , pp. 839-845
- Zhang, L.Q.¹ Chung, C.² Hu, B.S.³ He, T.⁴ Guo, Y.⁵ Kim, A.J.⁶ Skulsky, E.⁷ Jin, X.⁸ Hurley, A.⁹ Ramratnam, B.¹⁰ Markowitz, M.¹¹ Ho, D.D.¹²

78
- 0033609373
- Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
- Zhang, L. Q., B. Ramratnam, K. Tenner-Racz, Y. X. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A. S. Perelson, B. T. Korber, M. Markowitz, and D. D. Ho. 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340:1605-1613.
- (1999) N. Engl. J. Med. , vol.340 , pp. 1605-1613
- Zhang, L.Q.¹ Ramratnam, B.² Tenner-Racz, K.³ He, Y.X.⁴ Vesanen, M.⁵ Lewin, S.⁶ Talal, A.⁷ Racz, P.⁸ Perelson, A.S.⁹ Korber, B.T.¹⁰ Markowitz, M.¹¹ Ho, D.D.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.